$178.90
Price
$9.2B
Market Cap
—
P/E Ratio
29.4
Forward P/E
$-3.69
EPS (TTM)
—
Dividend Yield
$323M
Cash
$218M
Total Debt
51M
Shares Out
$93.95
$191.50
52-Week Range
Institutional Ownership of Axsome Therapeutics
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Axsome Therapeutics
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | +2.1% | 17.4K | $2M | $111.70 | |
| SELL | EXIT | — | — | $111.70 | |
| 2025-Q2 | |||||
| SELL | -0.3% | 17.1K | $2M | $105.41 | |
| BUY | NEW | 3.2K | $337388 | $105.41 | |
| 2025-Q1 | |||||
| SELL | -0.3% | 17.1K | $2M | $119.50 | |
| 2024-Q4 | |||||
| BUY | +45.3% | 17.2K | $1M | $90.97 | |
| 2024-Q3 | |||||
| BUY | +0.7% | 11.8K | $1M | $86.17 | |
| 2024-Q2 | |||||
| BUY | +11.5% | 11.7K | $945634 | $74.18 | |
| 2024-Q1 | |||||
| BUY | NEW | 10.5K | $840932 | $82.95 | |
Insider Trading for Axsome Therapeutics
6 Months Insider Sentiment
Buy $0
Sell $63.6M
0
Buys
11
Sells
-63.6M
Net
0
Grants
Largest
$13.5M
HERRIOT
$12.1M
HERRIOT
$7.1M
HERRIOT
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 07, 2026 | TABUTEAU HERRIOT | Chief Executive Officer | SELL | 31.3K | $170.38 | $5.3M |
| Jan 07, 2026 | TABUTEAU HERRIOT | Chief Executive Officer | EXERCISE | 31.3K | $8.02 | $251K |
| Jan 06, 2026 | TABUTEAU HERRIOT | Chief Executive Officer | SELL | 29.4K | $172.33 | $5.1M |
| Jan 06, 2026 | TABUTEAU HERRIOT | Chief Executive Officer | EXERCISE | 29.4K | $8.02 | $236K |
| Jan 05, 2026 | TABUTEAU HERRIOT | Chief Executive Officer | SELL | 78.7K | $171.28 | $13.5M |
| Jan 05, 2026 | TABUTEAU HERRIOT | Chief Executive Officer | EXERCISE | 78.7K | $8.02 | $631K |
| Dec 31, 2025 | Mark E Saad | Director | EXERCISE | 6.2K | $8.02 | $50K |
| Dec 31, 2025 | Mark E Saad | Director | EXERCISE | 31.3K | $4.95 | $155K |
| Dec 31, 2025 | Mark E Saad | Director | SELL | 6.2K | $165.18 | $1.0M |
| Dec 31, 2025 | Mark E Saad | Director | SELL | 31.3K | $165.18 | $5.2M |
| Dec 04, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | EXERCISE | 10.6K | $8.02 | $85K |
| Dec 04, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | SELL | 10.6K | $148.18 | $1.6M |
| Dec 03, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | EXERCISE | 20.2K | $8.02 | $162K |
| Dec 03, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | SELL | 20.2K | $146.94 | $3.0M |
| Dec 02, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | EXERCISE | 49.3K | $8.02 | $395K |
| Dec 02, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | SELL | 49.3K | $144.59 | $7.1M |
| Nov 05, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | SELL | 21.8K | $134.49 | $2.9M |
| Nov 05, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | EXERCISE | 21.8K | $8.02 | $175K |
| Nov 04, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | SELL | 50.5K | $133.79 | $6.8M |
| Nov 04, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | EXERCISE | 50.5K | $8.02 | $405K |
| Nov 03, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | SELL | 91.7K | $132.34 | $12.1M |
| Nov 03, 2025 | TABUTEAU HERRIOT | Chief Executive Officer | EXERCISE | 91.7K | $8.02 | $735K |